Our preliminary work has also demonstrated that engineered bacteria VNP20009, designed to express apoptosis-inducing factor (AIF) and programmed cell death protein 1 (PD-1), successfully inhibits the progression of melanoma in mice (Wang et al. 2020; Zhou et al. 2022). Here, PDCD1 is linked to melanoma.